Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Weill-Cornell Medical College
mi
from
New York, NY
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  8/10/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis After Allogeneic Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 8/10/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
Richard L. Roudebush VA Medical Center
mi
from
Indianapolis, IN
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
Richard L. Roudebush VA Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Treatment of Sleep Disturbances in Young Children With Autism
Treatment of Sleep Disturbances in Young Children With Autism
Status: Enrolling
Updated:  8/11/2015
Children's Hospital of Pittsburgh Autism Cetner
mi
from
Pittsburgh, PA
Treatment of Sleep Disturbances in Young Children With Autism
Treatment of Sleep Disturbances in Young Children With Autism
Status: Enrolling
Updated: 8/11/2015
Children's Hospital of Pittsburgh Autism Cetner
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Cognitive Behavior Therapy for Anxiety in Dementia
Status: Enrolling
Updated:  8/12/2015
Baylor College of Medicine
mi
from
Houston, TX
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Cognitive Behavior Therapy for Anxiety in Dementia
Status: Enrolling
Updated: 8/12/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Cognitive Behavior Therapy for Anxiety in Dementia
Status: Enrolling
Updated:  8/12/2015
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
Cognitive Behavior Therapy for Anxiety in Dementia
Status: Enrolling
Updated: 8/12/2015
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
Improving Medication Use for ADHD in Primary Care
Status: Enrolling
Updated:  8/14/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
Improving Medication Use for ADHD in Primary Care
Status: Enrolling
Updated: 8/14/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Indianapolis Neurosurgical Group
mi
from
Indianapolis, IN
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Indianapolis Neurosurgical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Washington University
mi
from
St. Louis, MO
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Virginia
mi
from
Charlottesville, VA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Alabama
mi
from
Birmingham, AL
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of California
mi
from
San Francisco, CA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Florida
mi
from
Gainesville, FL
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Maryland
mi
from
Baltimore, MD
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Michigan
mi
from
Ann Arbor, MI
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
The Mayo Clinic
mi
from
Rochester, MN
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Columbia University
mi
from
New York, NY
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
University of Cincinnati Department of Neurology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated:  8/17/2015
Univ of Washington
mi
from
Seattle, WA
Familial Intracranial Aneurysm Study II
Familial Intracranial Aneurysm Study II
Status: Enrolling
Updated: 8/17/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
Cortical Excitability: Phenotype and Biomarker in ADHD Therapy
Status: Enrolling
Updated:  8/17/2015
University of Cincinnati
mi
from
Cincinnati, OH
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
Cortical Excitability: Phenotype and Biomarker in ADHD Therapy
Status: Enrolling
Updated: 8/17/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
Cortical Excitability: Phenotype and Biomarker in ADHD Therapy
Status: Enrolling
Updated:  8/17/2015
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
Cortical Excitability: Phenotype and Biomarker in ADHD Therapy
Status: Enrolling
Updated: 8/17/2015
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Status: Enrolling
Updated:  8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Status: Enrolling
Updated: 8/17/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Status: Enrolling
Updated:  8/17/2015
Columbia Medical Center NY
mi
from
New York, NY
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Status: Enrolling
Updated: 8/17/2015
Columbia Medical Center NY
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Sharp Rehabilitation Center
mi
from
San Diego, CA
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Sharp Rehabilitation Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Brooks Center for Rehabilitation Studies
mi
from
Jacksonville, FL
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Brooks Center for Rehabilitation Studies
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Kansas University Medical Center
mi
from
Kansas City, KA
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
St.Charles Hospital & Rehabilitation
mi
from
Port Jefferson, NY
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
St.Charles Hospital & Rehabilitation
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
The Drake Center /University of Cincinnati
mi
from
Cincinnati, OH
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
The Drake Center /University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Rancho Los Amigos National Rehabilitation Center
mi
from
Downey, CA
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
National Rehabilitation Hospital
mi
from
Washington,
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
National Rehabilitation Hospital
mi
from
Washington,
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
Weill Cornell Medical Center
mi
from
New York, NY
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
UT Southwestern
mi
from
Dallas, TX
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
UT Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated:  8/18/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Status: Enrolling
Updated: 8/18/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.
A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.
Status: Enrolling
Updated:  8/18/2015
Hoopes Vision
mi
from
Salt Lake City, UT
The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.
A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.
Status: Enrolling
Updated: 8/18/2015
Hoopes Vision
mi
from
Salt Lake City, UT
Click here to add this to my saved trials